IL10 and Insulin resistance: The intervention resulted in decreased visceral fat and tumor necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) levels and increased levels of interleukin-10 (IL-10) and adiponectin, accompanied by a reduction in homeostatic model assessment-insulin resistance (HOMA-IR) and the occurrence of associated diseases [25–28].